FTSE MIB
33.908,61 +27,11 (+0,08%) Dow Jones
37.919,81 +144,43 (+0,38%) Nasdaq
15.466,37 -135,13 (-0,87%) Nikkei 225
37.068,35 -1.011,35 (-2,66%) Petrolio
83,24 +0,51 (+0,62%) Bitcoin EUR
60.422,84 +591,23 (+0,99%)
Baxter International Inc. (0QK8.L)
| Chiusura precedente | 39,45 |
| Aperto | 39,68 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 39,68 - 40,07 |
| Intervallo di 52 settimane | 31,02 - 50,10 |
| Volume | |
| Media Volume | 2.981 |
| Capitalizzazione | N/D |
| Beta (5 anni mensile) | 0,63 |
| Rapporto PE (ttm) | 0,19 |
| EPS (ttm) | 2,09 |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireCORRECTION – Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing
Tigris patient enrollment momentum continues reaching 72 The Company anticipates three additional trial sites to be activated in Q3 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CORRECTION FROM SOURCE: Spectral Medical Inc. A correction from source is being issued with respect to the press release titled, Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing, released on September 7, 2023, at 7:00 am ET. There was an
- GlobeNewswire
Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing
Tigris patient enrollment momentum continues reaching 72 The Company anticipates three additional trial sites to be activated in Q3 NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the “Company”) is pleased to announce that it has closed its previously announced ”bought deal” private placement of 9.0% convertible unsecured senior notes due November 1, 2026
